Clinical Trial Update: Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating memantine to prevent cognitive/functional side effects in patients with brain metastases undergoing whole-brain radiation therapy; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Cancer

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Cognitive/Functional Effects, Metastatic Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-07-21